| Biocon Limited Announces Earnings for the Half Year Ended September 30, 2011 - Business Wire India (press release) |
|
|
Business Wire India (press release) Nephrology – The second quarter of FY12 saw the Nephrology business unit deliver a strong double-digit growth of 18% driven by a strong 25% growth in the renal transplant portfolio comprising of TacrografTM, RenodaptTM, and Cyclophil METM. |